Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 38, Issue 8, 2004, Pages

  Launay, O ^a   Roudiere L ^a   Boukli, N ^a   Dupont, B ^a   Prevoteau du Clary F ^a   Patey, O ^a   David, F ^a   Lortholary, O ^a   Devidas, A ^a   Piketty, C ^a   Rey, E ^a   Urbinelli, R ^a   Allaert, F A ^a   Treluyer J M ^a   Caumes, E ^a  

^a AP HP ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; NEVIRAPINE; PLACEBO;

ADULT; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INCIDENCE; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RASH;

ADULT; ANTI-HIV AGENTS; CETIRIZINE; DOUBLE-BLIND METHOD; EXANTHEMA; FEMALE; HISTAMINE H1 ANTAGONISTS; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; NEVIRAPINE; PLACEBOS;

MLCS; MLOWN;

EID: 2342576996     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/382677     Document Type: Article

References (0)